Thanunrat Thongmee

Chulalongkorn University — Thailand

Medicine · Health Sciences

22h-index1.5kcitations92works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(42), COVID-19 Clinical Research Studies(26), Animal Virus Infections Studies(21), Hepatitis Viruses Studies and Epidemiology(16), Viral gastroenteritis research and epidemiology(12)

Publications92 total

Low Prevalence of Zika Virus RNA Among Thai Blood Donors
Vector-Borne and Zoonotic Diseases·2026
Longitudinal RSV Antibody Trends in Thai Children (0–8 Years): Association With Seasonal Outbreak Patterns and Potential Immunity Debt During the COVID‐19 Pandemic
Journal of Medical Virology·2025
Chikungunya virus in Thailand (2020–2023): Epidemiology, clinical features, and genomic insights
PLoS neglected tropical diseases·2025· 2 citedOpen Access
Epstein–Barr Virus Seroprevalence in Thailand: A Temporal and Global Perspective with Health Care and Economic Correlations
American Journal of Tropical Medicine and Hygiene·2025· 1 cited
Age-Specific Seroprevalence of Measles, Mumps, and Rubella IgG across All Age Groups in Chonburi Province, Thailand after the Coronavirus Disease 2019 Pandemic
American Journal of Tropical Medicine and Hygiene·2025· 1 cited
Seroprevalence of antibodies against diphtheria, tetanus, and pertussis across various age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand
Heliyon·2024· 7 citedOpen Access
Seroprevalence of antibodies against varicella zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand
Human Vaccines & Immunotherapeutics·2024· 1 citedOpen Access
Persistence of Antibodies against Measles, Mumps, and Rubella after the Two-Dose MMR Vaccination: A 7-Year Follow-Up Study
Vaccines·2024· 4 citedOpen Access
Antibody persistence to diphtheria toxoid, tetanus toxoid, <i>Bordetella pertussis</i> antigens, and <i>Haemophilus influenzae</i> type b following primary and first booster with pentavalent versus hexavalent vaccines
Human Vaccines & Immunotherapeutics·2024· 6 citedOpen Access
Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection
Vaccines·2024· 5 citedOpen Access
Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3–4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination
Heliyon·2023· 6 citedOpen Access
Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/ChAdOx-1nCov-19 vaccination
Human Vaccines & Immunotherapeutics·2023· 1 citedOpen Access
Prevalence and the impact of hepatitis E infection in pediatric liver transplanted recipients with hepatitis in Thailand
Pediatric Transplantation·2023
Safety and Efficacy of a Third Dose of the BNT162b2 Vaccine in Liver‐Transplanted and Healthy Adolescents
JPGN Reports·2023Open Access
Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023
Scientific Reports·2023· 15 citedOpen Access
SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis
Vaccines·2023· 12 citedOpen Access
Evaluation of Anti-S1 IgA Response to Different COVID-19 Vaccination Regimens
Vaccines·2023· 2 citedOpen Access
Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6 months of age
Vaccine·2023· 12 cited
Su1531 PREVALENCE OF HEPATITIS E INFECTION IN LIVER TRANSPLANTED CHILDREN: A SINGLE CENTRE EXPERIENCE
Gastroenterology·2023
Comparison of the reactogenicity and immunogenicity between two‐dose mRNA COVID‐19 vaccine and inactivated COVID‐19 vaccine followed by an mRNA vaccine in children aged 5−11 years
Journal of Medical Virology·2023· 4 cited
page 1 of 5Next →

Frequent Co-authors

Yong Poovorawan(50), Nasamon Wanlapakorn(32), Preeyaporn Vichaiwattana(28), Nungruthai Suntronwong(27), Sirapa Klinfueng(26), Donchida Srimuan(23), Sitthichai Kanokudom(20), Suvichada Assawakosri(20), Natthinee Sudhinaraset(20), Chompoonut Auphimai(19), Ritthideach Yorsaeng(18), Thaksaporn Thatsanatorn(18), Sompong Vongpunsawad(17), Pornjarim Nilyanimit(15), Jira Chansaenroj(15), Apiradee Theamboonlers(12), Thaneeya Duangchinda(9), Warangkana Chantima(9), Pattarakul Pakchotanon(9), Sittisak Honsawek(7)